Archives - Market Regulation
-
4 November 2012 Principles for the Ongoing Disclosure of Asset-Backed Securities
The Principles for Ongoing Disclosure for Asset Backed Securities aim to enhance investor protection by providing guidance to regulators that are developing or reviewing their disclosure regimes for offerings and listings of asset backed securities. -
2 October 2012 Principles for Oil Price Reporting Agencies
These principles detail a set of recommended practices for Price Reporting Agencies (PRAs) that produce assessments which are referenced by oil derivatives contracts. -
3 June 2012 Regulation of Institutional Investors in Emerging Markets
This report makes recommendations to help emerging market regulators and policy makers develop and regulate institutional investors. -
1 June 2012 International Standards for Derivatives Market Intermediary Regulation
This report focuses on the regulation of Derivatives Market Intermediaries (DMIs). The recommendations in the report are intended to address: DMI obligations that should help mitigate systemic risks; requirements intended to manage counterparty risk; and protecting participants in the OTC derivatives markets from unfair, improper or fraudulent practices. -
18 April 2012 Principles for Financial Market Infrastructures
This document contains 24 principles to be observed by financial market infrastructures (systemically important payment systems, central securities depositories, securities settlement systems, central counterparties and trade repositories) and five responsibilities of relevant authorities in regulating, supervising and overseeing these infrastructures. -
2 February 2012 Requirements for Mandatory Clearing
This report outlines recommendations that authorities should follow in establishing a mandatory clearing regime within their jurisdiction. -
1 January 2012 Report on OTC Derivatives Data Reporting and Aggregation Requirements
Obligation of OTC derivatives contracts to be reported to trade repositories (TRs) in order to improve transparency, mitigate systemic risk and protect against market abuse in the OTC derivatives markets.